Meridian Bioscience meets 4Q profit forecasts

CINCINNATI (AP) _ Meridian Bioscience Inc. (VIVO) on Thursday reported fiscal fourth-quarter net income of $5.7 million.

On a per-share basis, the Cincinnati-based company said it had net income of 13 cents. Earnings, adjusted for non-recurring costs, came to 15 cents per share.

The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of 15 cents per share.

The diagnostic test maker posted revenue of $49.7 million in the period.

For the year, the company reported profit of $21.6 million, or 51 cents per share. Revenue was reported as $200.8 million.

Meridian Bioscience expects full-year earnings in the range of 65 cents to 68 cents per share, with revenue in the range of $207 million to $212 million.

Meridian Bioscience shares have fallen 17 percent since the beginning of the year. The stock has decreased 10 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VIVO at https://www.zacks.com/ap/VIVO